Advanced Pharmaceutical Bulletin's 2026 Journal Metrics Score is 1.5, ranking Q3 in Pharmaceutical Science. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 3.51.
Middle 50%: 116–246 days
100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025
No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
18 of 255 works · same type, year & subfield
2 works · same type, year & subfield
Below field-year expectation
of 1,017 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.64, so its typical recent paper runs about 36% below its field benchmark.
7.1% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
255 OpenAlex works · 2021–2024
OpenAlex topics show the research communities this journal serves.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Pharmaceutical Science | Q3 |
| Biomaterials | Q4 |
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
Advanced Pharmaceutical Bulletin's 2026 Journal Metrics Score is 1.5, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
Advanced Pharmaceutical Bulletin's best quartile is Q3. By OpenAlex subfield: Q3 in Pharmaceutical Science; Q4 in Biomaterials. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Advanced Pharmaceutical Bulletin will not match this score exactly. Compare journals using one source at a time.
Across 100 recent PubMed records with both dates, Advanced Pharmaceutical Bulletin took a median of 181 days from submission to acceptance; the middle half took 116–246 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.
Comparable journals include Drug Delivery and Translational Research, Pharmaceutics, International Journal of Pharmaceutics, and Expert Opinion On Drug Delivery. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.